ESO-ESSO Masterclass in Colorectal Cancer Surgery

12-17 February 2011, Cascais, Portugal

FACULTY

Chair: T. Wiggers, NL – L. Påhlman, SE – K. Havenga, NL

G. Baatrup, Haukeland University Hospital, Department of Surgery, Section of Colorectal Surgery, Bergen, NO
H. Becker, Georg-August-University, Department of General Surgery, Göttingen, DE
G. Beets, Academic Hospital Maastricht, Department of Surgery, Maastricht, NL
R. Beets-Tan, Academic Hospital Maastricht, Department of Radiology, Maastricht, NL
A. Bembenek, Hannover Regional Clinic, Department of Visceral Surgery, Hannover, DE
J.F. Bosset, Jean Minjoz Hospital Centre, Department of Radiation Therapy, Besançon, FR
M. DeRuiter, Leiden University Medical Center, Department of Anatomy and Embryology, Leiden, NL
K. Havenga, University Medical Centre Groningen, Department of Surgery, Groningen, NL
T. Holm, Karolinska University Hospital, Department of Surgery, Stockholm, SE
B. Moran, Basingstoke & North Hampshire Foundation Trust, Department of Colorectal Cancer, Basingstoke, UK
L. Påhlman, University Hospital Uppsala, Department of Surgical Sciences, Section of Surgery, Uppsala, SE
G. Poston, Aintree University Hospital, Department of Surgery, Liverpool, UK
D. Sebag-Montefiore, University of Leeds , Leeds Cancer Centre, Department of Clinical Oncology, Leeds, UK
E. Tiret, Saint-Antoine Hospital, Centre for Digestive Surgery, Paris, FR
T. Wiggers, University Medical Centre Groningen, Department of Surgery, Groningen, NL


AIMS AND OBJECTIVES

Based on knowledge of total mesocolon and total mesorectal surgery and imaging before the operation, after the Masterclass participants will be able to answer the 10 following questions:

1. Is screening to be implemented?
2. How does staging influence clinical decision making?
3. Which information may influence treatment choices?
4. Where do I damage the autonomic nerve plexus?
5. How and when can I minimize the procedure?
6. How do I position the patient for the perineal phase and perform a wide  
    excision for low rectal cancers?
7. How do I deal with the loss of a pelvic floor after a wide perineal resection 
    and how do I correct a perineal hernia?
8. How do I estimate the need of a defunctioning colostomy and how do I 
    treat leakage of the anastomosis?
9. How do I treat a patient with colorectal cancer and synchronous liver
    metastases?
10. How do I balance the advantages and disadvantages of adjuvant
      treatment (numbers needed to treat)?

TEACHING FORMAT

The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will conclude in take-home messages.
Workshop sessions in small groups will be organised in areas of decision making in complex cases. Furthermore, participants will deliver case presentations within small groups and discuss these with the chairmen and the faculty.

All participants will reside at the course venue and participation is compulsory throughout the course.

The Masterclass will be entirely in English and fluency in English is necessary for admission.

THE MASTERCLASS IS:

• A 5-day residential educational event
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts will contribute to the programme


IDEAL MASTERCLASS CANDIDATE

• Age between 30 and 40 years
• Resident of surgery in the last two years of specialisation with clinical interest in colorectal   cancer, or surgical oncologists and colorectal surgeons within 5 years of ending specialisation residency,  or medical and radiation oncologists with 3-5 years of experience  in the treatment of colorectal cancer patients
• Involvement in scientific activities
• Fluency in English

PARTICIPATION

Attendance is limited to 40 participants and admittance is by competitive application only. The successful applicants are granted free registration but a contribution to the costs of full-board accommodation at the course venue (EUR 500) and travel are to be covered by the participants.

HOW TO APPLY

Interested oncologists, residents in surgery and surgeons should fill in the  application form and provide the following documents by the deadline of 1st October 2010:

• Letter describing motivation for attending
• Short CV (max. 2 pages) describing recent clinical experience and list of recent publications
• Supporting letter from Head of Department or Mentor
• Abstract (see below) with proposed presentation of a clinical case of a colorectal cancer patient

The abstract (max. 1 page) should describe a clinical case in the form of a clinical grand-round with:
• Diagnostic considerations
• Treatment
• Outcome (follow-up)
• At least three questions that the applicant proposed for discussion with the faculty and    participants

After the selection, four participants will furthermore be invited to give a presentation on specific topics.

ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY

APPLICATION DEADLINE: 1 OCTOBER


FOR MORE INFORMATION CONTACT

Carine Lecoq
ESSO administrator

European Society of Surgical Oncology (ESSO)
avenue E. Mounier 83
B-1200 Brussels
Tel: +32 2 537 31 06
Fax: +32 2 539 03 74
e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
url: www.essoweb.org

or download the announcement flyer

ACCREDITATION

Application for CME recognition will be submitted to the Accreditation Council for Oncology in Europe.

PARTNERSHIP

This masterclass is a joint ESO-ESSO parntership